Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04073290Phase 4Recruiting
Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose
Cirrhosis, LiverHepatic EncephalopathyLiver Diseases+2 more
PrincipalinvestigatorStart date: 2020-01-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

Liver CirrhosisHypertension, PortalHepatic Encephalopathy+1 more
Similarity Score20%

Averell Sherker, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
11 trials

Shared therapeutic areas:

Liver CirrhosisLiver DiseasesHepatic Encephalopathy+1 more
Similarity Score20%

Ed Doo, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Related
13 trials

Shared therapeutic areas:

Liver DiseasesHepatic EncephalopathyHypertension, Portal
Similarity Score15%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Liver CirrhosisLiver Diseases
Similarity Score10%

Flemming Forsberg, phD

Thomas Jefferson University

Related
9 trials

Shared therapeutic areas:

Hypertension, PortalLiver Diseases
Similarity Score10%

Arnulf Ferlitsch, MD

Medical University of Vienna

Related
9 trials

Shared therapeutic areas:

Hypertension, PortalLiver Cirrhosis
Similarity Score10%

Art Wheeler, MD

Cumberland Pharmaceuticals

Related
13 trials

Shared therapeutic areas:

Liver DiseasesLiver Cirrhosis
Similarity Score10%

Xiaolong Qi, M.D.

LanZhou University

Related
5 trials

Shared therapeutic areas:

Hypertension, PortalLiver Cirrhosis
Similarity Score10%

Guo-Qing Jiang, MD

Clinical Medical College of Yangzhou University

Related
10 trials

Shared therapeutic areas:

Liver CirrhosisHypertension, Portal
Similarity Score10%

Bruno SF Souza, MD, Msc

Hospital São Rafael

Related
5 trials

Shared therapeutic areas:

Liver Cirrhosis
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04073290Phase 4PrincipalInvestigator

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

Cirrhosis, LiverHepatic EncephalopathyLiver Diseases+2 more
Recruiting

All 1 trials loaded